Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy

More than twice as many patients with hypertrophic cardiomyopathy treated with the investigational agent mavacamten had a very large improvement in quality of life vs placebo in EXPLORER-HCM.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news